Skip to content

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

Randomized Trial of Laparoscopic Versus Abdominal Hysterectomy for Benign Indications and Impact on Surgical Success

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01793584
Enrollment
100
Registered
2013-02-15
Start date
2013-02-28
Completion date
2016-12-31
Last updated
2017-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis, Endometriosis, Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Inflammatory Disease, Pelvic Pain

Keywords

Comparative effectiveness, Surgical success

Brief summary

The purpose of the proposed pilot study is to investigate the effectiveness, cost, safety, and long-term impact on quality of life of laparoscopic hysterectomy (LH) in relation to abdominal hysterectomy (AH) for the treatment of benign gynecologic disease in women through a randomized surgical trial.

Detailed description

The overall hypothesis is that neither mode of hysterectomy will be consistently superior to the other with respect to each of the three domains of complications, cost, and patient-centered outcomes. The overall goal of the study is to determine which clinically relevant factors may impact the choice of LH compared to AH. The results of the study may be useful for clinicians, patients, hospital administrators and health policy makers.

Interventions

PROCEDURELaparoscopic hysterectomy

LAVH, TLH

PROCEDUREAbdominal hysterectomy

TAH

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Women undergoing hysterectomy for benign indications within 8 weeks of enrollment * Women \>18 years of age * Non-emergent surgery * Non-pregnant

Exclusion criteria

* Candidate for vaginal hysterectomy * Uterine size \>14 weeks by clinical exam OR \>300 mL by ultrasound measurement * History of cancer of reproductive tract * Requires concomitant pelvic organ prolapse (POP) surgery * Requires surgery for urinary incontinence * Has acute angle glaucoma * Has severe cardiac/respiratory disease * Desires supracervical hysterectomy

Design outcomes

Primary

MeasureTime frameDescription
Quality of life1 year1\) Patient-centered outcomes composite 1. Quality of life - measured using the Short Form 12 (SF-12v2), 2. Sexual functioning - measured using the Sexual Activity Questionnaire (SAQ) 3. Body image - measured using the Body Image Scale (BIS) 4. Return to normal activity -measured using the Activities Assessment Scale (AAS) 5. Pain - measured using a 10 point likert scale 6. Productivity - measured using a questionnaire about missed work

Secondary

MeasureTime frameDescription
Cost1 yearHospital charges and indirect costs of missed work/caregiving due to hysterectomy will be calculated
Complications1 yearIntraoperative and postoperative complications including conversions, unintentional lacerations/injury to organs, hemorrhage, infection, wound complications, VTE, death, pain, neuropathy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026